Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
Deliyannis G, Wong CY, McQuilten HA, Bachem A, Clarke M, Jia X, Horrocks K, Zeng W, Girkin J, Scott NE, Londrigan SL, Reading PC, Bartlett NW, Kedzierska K, Brown LE, Mercuri F, Demaison C, Jackson DC, Chua BY. Deliyannis G, et al. JCI Insight. 2021 Mar 8;6(5):e140267. doi: 10.1172/jci.insight.140267. JCI Insight. 2021. PMID: 33561017 Free PMC article.
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.
Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, Smith C, Zeng W, Brown LE. Jackson DC, et al. Among authors: deliyannis g. Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15440-5. doi: 10.1073/pnas.0406740101. Epub 2004 Oct 15. Proc Natl Acad Sci U S A. 2004. PMID: 15489266 Free PMC article.
ISCOM-based vaccines: the second decade.
Sanders MT, Brown LE, Deliyannis G, Pearse MJ. Sanders MT, et al. Among authors: deliyannis g. Immunol Cell Biol. 2005 Apr;83(2):119-28. doi: 10.1111/j.1440-1711.2005.01319.x. Immunol Cell Biol. 2005. PMID: 15748208 Review.
36 results